In a randomized longitudinal clinical trial designed to evaluate two or more rival treatments, an intent-to-treat analysis requires inclusion of all randomized patients, regardless of whether they remain on protocol for the duration of the study. We propose a piecewise linear random effects model for analyzing longitudinal data where the multivariate outcome can depend upon time spent on treatment. The model assumes that data are available on a random sample of subjects after treatment is terminated, and allows either a pragmatic or explanatory analysis (as defined by Schwartz and Lellouch, 1967, Journal of Chronic Diseases 20, 637-648). Full maximum likelihood estimation of the model parameters is carried out using widely available statistical software for repeated measures with missing data and for nonparametric survival curve estimation. Data from a national, multicenter pediatric AIDS clinical trial are analyzed to illustrate implementation and interpretation of the model.
No takes yet. Share an insight, caveat, or question.
Hogan et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: